Diagnostic utility of clinical and laboratory test parameters for differentiating between sudden acquired retinal degeneration syndrome and pituitary-dependent hyperadrenocorticism in dogs
- PMID: 30864251
- DOI: 10.1111/vop.12661
Diagnostic utility of clinical and laboratory test parameters for differentiating between sudden acquired retinal degeneration syndrome and pituitary-dependent hyperadrenocorticism in dogs
Abstract
Objective: To identify discriminating factors, using clinical ophthalmic examination findings and routine laboratory testing, that differentiate dogs with early sudden acquired retinal degeneration (SARDS; vision loss <6 weeks' duration), age- and breed-matched control dogs, and dogs with pituitary-dependent hyperadrenocorticism (PDH).
Animals: Client-owned dogs: 15 with SARDS with <6 weeks duration of vision loss, 14 age- and breed-matched control dogs, and 13 dogs with confirmed PDH.
Procedures: Dogs underwent ophthalmic examination, electroretinography (ERG) fundus photography, and spectral-domain optical coherence tomography (SD-OCT) in addition to physical examination, urinalysis, serum biochemistry, complete blood count, and adrenocorticotrophic hormone (ACTH) stimulation testing. Statistical analysis was performed using receiver operating curve area under the curve analysis, principal component analysis with sparse partial least squares analysis, and one-way ANOVA.
Results: Dogs with SARDS all had absent vision and ERG a- and b-waves. SD-OCT demonstrated that dogs with SARDS had significantly thicker inner retina, thinner outer nuclear layer, and thicker photoreceptor inner/outer segment measurements than either controls or dogs with PDH. Discriminating laboratory parameters between dogs with SARDS and PDH with high specificity included post-ACTH serum cortisol (<19.3 μg/dL), AST:ALT ratio (>0.343), and urine specific gravity (>1.030).
Conclusions and clinical relevance: We have identified significant discriminators between SARDS and PDH. This work provides the basis for future studies that could identify and examine dogs with SARDS prior to vision loss, which may extend the potential therapeutic window for SARDS.
Keywords: biomarker; dog; hyperadrenocorticism; retina; sudden acquired retinal degeneration syndrome.
© 2019 American College of Veterinary Ophthalmologists.
Similar articles
-
Circulating neurohormone imbalances in canine sudden acquired retinal degeneration syndrome and canine pituitary-dependent hypercortisolism.J Vet Intern Med. 2019 Nov;33(6):2587-2594. doi: 10.1111/jvim.15646. Epub 2019 Oct 29. J Vet Intern Med. 2019. PMID: 31660652 Free PMC article.
-
Optical coherence tomography and molecular analysis of sudden acquired retinal degeneration syndrome (SARDS) eyes suggests the immune-mediated nature of retinal damage.Vet Ophthalmol. 2019 May;22(3):305-327. doi: 10.1111/vop.12597. Epub 2018 Aug 15. Vet Ophthalmol. 2019. PMID: 30109754 Free PMC article.
-
Evaluation of retinal morphology of canine sudden acquired retinal degeneration syndrome using optical coherence tomography and fluorescein angiography.Vet Ophthalmol. 2019 Jul;22(4):398-406. doi: 10.1111/vop.12602. Epub 2018 Aug 22. Vet Ophthalmol. 2019. PMID: 30136357
-
Sudden acquired retinal degeneration syndrome (SARDS) - a review and proposed strategies toward a better understanding of pathogenesis, early diagnosis, and therapy.Vet Ophthalmol. 2016 Jul;19(4):319-31. doi: 10.1111/vop.12291. Epub 2015 Jun 20. Vet Ophthalmol. 2016. PMID: 26096588 Review.
-
Acute Blindness.Top Companion Anim Med. 2015 Sep;30(3):118-25. doi: 10.1053/j.tcam.2015.07.005. Epub 2015 Jul 9. Top Companion Anim Med. 2015. PMID: 26494503 Review.
Cited by
-
Changes in retinal layer thickness with maturation in the dog: an in vivo spectral domain - optical coherence tomography imaging study.BMC Vet Res. 2020 Jun 30;16(1):225. doi: 10.1186/s12917-020-02390-8. BMC Vet Res. 2020. PMID: 32605619 Free PMC article.
-
Effects of Oral Macrocyclic Lactone Heartworm Preventatives on Retinal Function and Chromatic Pupillary Light Reflex in Healthy Companion Dogs.Vet Ophthalmol. 2025 Feb 2:10.1111/vop.13319. doi: 10.1111/vop.13319. Online ahead of print. Vet Ophthalmol. 2025. PMID: 39894736
-
Circulating neurohormone imbalances in canine sudden acquired retinal degeneration syndrome and canine pituitary-dependent hypercortisolism.J Vet Intern Med. 2019 Nov;33(6):2587-2594. doi: 10.1111/jvim.15646. Epub 2019 Oct 29. J Vet Intern Med. 2019. PMID: 31660652 Free PMC article.
-
Canine sudden acquired retinal degeneration syndrome: Owner perceptions on the time to vision loss, treatment outcomes, and prognosis for life.Vet Ophthalmol. 2021 Mar;24(2):156-168. doi: 10.1111/vop.12855. Epub 2020 Dec 29. Vet Ophthalmol. 2021. PMID: 33377263 Free PMC article.
-
Hemostatic profiles in dogs with sudden acquired retinal degeneration syndrome.J Vet Intern Med. 2023 May-Jun;37(3):948-959. doi: 10.1111/jvim.16710. Epub 2023 Apr 19. J Vet Intern Med. 2023. PMID: 37073895 Free PMC article.
References
REFERENCES
-
- Komaromy AM, Abrams KL, Heckenlively JR, et al. Sudden acquired retinal degeneration syndrome (SARDS) - a review and proposed strategies toward a better understanding of pathogenesis, early diagnosis, and therapy. Vet Ophthalmol. 2016;19:319-331.
-
- Carter RT, Oliver JW, Stepien RL, Bentley E. Elevations in sex hormones in dogs with sudden acquired retinal degeneration syndrome (SARDS). J Am Anim Hosp Assoc. 2009;45:207-214.
-
- Stuckey JA, Pearce JW, Giuliano EA, et al. Long-term outcome of sudden acquired retinal degeneration syndrome in dogs. J Am Vet Med Assoc. 2013;243:1425-1431.
-
- Heller AR, van der Woerdt A, Gaarder JE, et al. Sudden acquired retinal degeneration in dogs: breed distribution of 495 canines. Vet Ophthalmol. 2017;20:103-106.
-
- Montgomery KW, van der Woerdt A, Cottrill NB. Acute blindness in dogs: sudden acquired retinal degeneration syndrome versus neurological disease (140 cases, 2000-2006). Vet Ophthalmol. 2008;11:314-320.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources